Cite
HARVARD Citation
Ivanov, V. et al. (2020). Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma. Leukemia & lymphoma. 61 (5), pp. 1230-1233. [Online].